The case for & against
Bull & Bear analysis
American Express Company (NYSE: AXP) is a leading global payments and travel-related services firm that focuses on delivering premium financial products primarily to high-net-worth individuals and small to medium-sized businesses. The company differentiates itself through its closed-loop business model, which fosters deep customer insights, targeted marketing, and strong customer loyalty, particularly among affluent consumers. With a strong emphasis on innovation and premium services, American Express continues to expand its footprint while capitalizing on trends among younger demographics, such as Millennials and Gen Z.
Bull says
- ↑Q2 revenue hit $15.9 B (+10% YoY) and EPS climbed to $4.53 (+11%).
- ↑Net card fees reached $1.7 B (+15.4% YoY) on increased travel and spending.
- ↑Issued 3 M new cards targeting Millennials and Gen Z, boosting user base.
- ↑Committed $2.9 B to shareholder returns ($0.6 B dividends, $2.2 B buybacks).
- ↑Delinquencies stable at 1.2–1.3%, reflecting robust credit quality.
- ↑High earnings yield, strong leverage use and solid institutional interest.
Bear says
- ↓Operating expenses rose 6% YoY on tech and marketing investments, squeezing margins.
- ↓Negative growth indicator suggests AXP may struggle to meet earnings expectations.
- ↓Dividend yield underperforms peers, raising concerns about future payouts.
- ↓Travel and entertainment exposure could hurt card fee growth in downturns.
- ↓Heavy reliance on premium cardholders risks attrition if spending shifts.
- ↓Low profitability and weak revision signals may dampen investor sentiment.
Investment themes with AXP
Stocks with high volatility relative to market
Digital and traditional payment processing solutions
Earnings Call · Q2 2025 · Mgmt. Guidance
Transcript signals
Bull points
- We think we're really good at managing that balance and finding the optimum point to generate value, to generate growth and sustainable value for our shareholders.
- I think we've learned a lot, and we believe that what we're going to come out with will be more than hold its own, be very, very competitive, and will continue to be innovative.
- revenue growth of 9% and earnings per share of $4.08, up 17%, reflecting our strong business model and strategy.
Bear points
- I guess what strikes me is that this may be the first time that you're doing this U.S. platinum refresh kind of into the teeth of a competitive environment.
- This quarter's results had about a one percentage point impact from the health for sale portfolios that we previously disclosed.
- While there continues to be uncertainty in how the coming quarters will play out, we have increased confidence in our path forward.